This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignees: Centre Hospitalier Regional Universitaire De Nancy, Universite Dé Lorraine. Active years: 2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 1 
1 out of 93 
Years Active: 2024
Title: Léonore Avercenc: Innovator in Stem Cell Research
Introduction
Léonore Avercenc is a notable inventor based in Nancy, France. He has made significant contributions to the field of stem cell research, particularly in the therapeutic applications of mesenchymal stem cells.
Latest Patents
Avercenc holds a patent for "Mesenchymal stem cells obtained from Wharton's jelly for the treatment of sepsis." This patent discloses a method for preparing human mesenchymal stem cells derived from Wharton's jelly, along with their therapeutic uses, especially for treating sepsis and septic shock. The treatment involves administering a pharmaceutical composition that includes these stem cells and a pharmaceutically acceptable excipient.
Career Highlights
Throughout his career, Léonore Avercenc has worked with esteemed institutions such as Université de Lorraine and Centre Hospitalier Régional Universitaire de Nancy. His work has focused on advancing the understanding and application of stem cell therapies.
Collaborations
Avercenc has collaborated with notable colleagues, including Danièle Bensoussan and Sébastien Gibot, contributing to the advancement of research in his field.
Conclusion
Léonore Avercenc's innovative work in stem cell research highlights the potential of mesenchymal stem cells in treating critical conditions like sepsis. His contributions continue to pave the way for future advancements in medical therapies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile